Patent · US Active

Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus

US7619094B2 · kind B2 · utility

4Cited by

2References

33Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Kevin X. Chen · Edison, US
F George Njoroge · Union, US
Mousumi Sannigrahi · Summit, US
Latha G. Nair · Edison, US
Weiying Yang · Edison, US
Bancha Vibulbhan · Kenilworth, US
Srikanth Venkatraman · Fords, US
Ashok Arasappan · Bound Brook, US
Stephane L. Bogen · Somerville, US
Frank Bennett · Piscataway, US
Viyyoor M. Girijavallabhan · Parsippany, US

Key dates

Filing date	Nov 20, 2006
Grant date	Nov 17, 2009
Priority date	—
Expiry date	Nov 20, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/707
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.